TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioEld Norden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,974
|
4,407
|
4,526 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2,333
|
1,862
|
2,178 |
| EBITDA |
1,616
|
1,755
|
2,176 |
| Total assets |
15,972
|
14,412
|
12,787 |
| Current assets |
4,048
|
7,539
|
6,577 |
| Current liabilities |
1,322
|
1,145
|
606 |
| Equity capital |
13,964
|
12,510
|
11,556 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
87.4%
|
86.8%
|
90.4% |
| Turnover per employee |
1,987
|
2,204
|
2,263 |
| Profit as a percentage of turnover |
58.7%
|
42.3%
|
48.1% |
| Return on assets (ROA) |
14.6%
|
12.9%
|
17.0% |
| Current ratio |
306.2%
|
658.4%
|
1085.3% |
| Return on equity (ROE) |
16.7%
|
14.9%
|
18.8% |
| Change turnover |
-433
|
-119
|
-1,091 |
| Change turnover % |
-10%
|
-3%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.